WebAug 1, 2012 · Radiation therapy can cause heart attack, heart failure, and arrhythmias. Traditional and novel chemotherapy agents can damage the heart or peripheral blood vessels, or cause problems with clotting or blood lipids. Some serious cardiovascular effects occur while the chemotherapy is being given; others appear long after cancer has become … WebNov 23, 2024 · Brief Summary: The therapeutic advantage of the association of ATRA + Arsenic Trioxide is more favorable and manageable as compared to ATRA + chemotherapy. Nevertheless, at present, there is not enough information on …
Trisenox (Arsenic Trioxide Injection): Uses, Dosage, Side …
Webmarketing authorisation of Trisenox for the treatment of relapsed acute promyelocytic leukemia in adult patients, characterised by the presence of the t(15;17) translocation and/or the presence of the ... With first line treatment combining ATRA and anthracycline based chemotherapy (CT), about 90% of the patients achieve complete response (CR ... WebFeb 16, 2024 · Chemotherapy kills fast-growing cells—both cancerous and non-cancerous—in the body. Immunotherapy helps the immune system do a better job of identifying cancer cells so it can attack and kill them. “Chemotherapy is a reactive approach. There’s a fast-growing cancer cell in your body, so you want to stop the fast-growing cells. pick 1 out of 20
Trisenox (arsenic trioxide) dosing, indications, interactions, …
Web78 anthracycline chemotherapy, and whose APL is characterized by the presence of the t(15;17) 79 translocation or PML/RAR-alpha gene expression. 80 The response rate of other acute myelogenous leukemia subtypes to TRISENOX™ has not 81 been examined. 82 CONTRAINDICATIONS 83 TRISENOX™ is contraindicated in patients who are … WebTRISENOX is indicated for induction of remission and consolidation in patients with APL who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression. 2 DOSAGE AND ADMINISTRATION . 2.1 . Recommended Dosage Webarsenic trioxide Trisenox Chemo Second line treatment of relapsed or refractory APL following ATRA plus an anthracycline. BCG, live Pacis Immunotherapy Treatment of carcinoma in situ (CIS) in the absence of associated invasive cancer of the bladder. ... chemotherapy or in patients who are intolerant to such therapy; Treatment of metastatic ... pick 1 out of 8